n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, September 25th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Yappn Corp. (YPPN)

MyBestStockAlerts, Fast Money Alerts, Penny Stock General, TopPennyStockMovers, SmallCapFinancialWire, PennyStocks24, Shiznit Stocks, Stock Shock and Awe, StockRunway, Orbit Stocks, SmallCapVoice, Information Solutions Group, and Social Hot Dog reported earlier on Yappn Corp. (YPPN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Yappn Corp. is a real-time innovative language solutions company that amplifies brand messaging, helps conduct commerce, and provides customer support through globalizing these experiences with its proprietary approach to language. Formed in 2010, Yappn provides people and brands the power to be social, conduct commerce, and communicate freely without a language barrier. OTCQB-listed, Yappn has its U.S. headquarters in New York, New York, and its Canadian headquarters in Markham, Ontario.

The Company provides products for ecommerce, customer care, enhanced messaging collaboration, as well as online marketing. In addition, Yappn provides custom translation solutions to different verticals. These include entertainment, retail, and marketing. The Company has its e-translation product. This is an advanced product that provides international vendors with the ability to integrate into leading ecommerce marketplace sites.

Yappn offers a complete customizable set of tools to engage consumers in greater than 100 languages. Yappn is free for users who want to participate on the Company’s general discussion board, unless otherwise noted.

A user’s language is detected by their browser setting automatically. At the very bottom of the page, a user will find a translator bar with the option to select numerous languages. A user chooses their language and all Yappn pages immediately translate. Everything a person sees on Yappn is in their language, regardless of the language in which it was first posted.

Yappn announced in April 2017 that it was granted a new patent for "Cross-Language Communication Between Proximate Mobile Devices" from the Commissioner of Patents representing the Australia Patent Office.  Additionally, the patent was separately granted in the U.S. on June 9, 2015 as Patent No. US 9,053,097 B2. Australian Patent No. 2012250625 was granted on March 9, 2017 and received by Yappn on March 22, 2017.

Yappn announced in May 2017 that it was granted a new patent for "Cross-Language Communication Between Proximate Mobile Devices" from the Commissioner of Patents representing the Canadian Patent Office. The patent was also separately granted in the U.S. on June 9, 2015 as Patent No. US 9,053,097 B2. Canadian Patent No. 2,835,110 was granted on April 11, 2017 and received by Yappn on May 3, 2017.

Fundamentally, Yappn approaches the challenge of real-time language translation in a completely inventive way. The result is enhanced translations based on the context of the content or discussion. As a result, this considerably improves the translation result. According to Common Sense Advisory, greater than 72 percent of consumers say they are more likely to buy online if the experience is in their preferred language.

Backed by its proprietary technology, Yappn’s advanced algorithms return translation with the correct meaning and context of the message. It does so in real-time. The Company’s system is built on an enterprise development methodology and hosted on Microsoft’s Azure® cloud-based platform.

Yappn Corp. (YPPN), closed Monday's trading session at $0.08, even for the day. The average volume for the last 60 days is 11,727 and the stock's 52-week low/high is $0.042/$0.75.

Escalon Medical Corp. (ESMC)

FeedBlitz, OTCPicks, Wall Street Resources, and PennyToBuck reported earlier on Escalon Medical Corp. (ESMC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Escalon Medical Corp. specializes in the development, marketing, and distribution of ophthalmic diagnostic imaging and surgical products. The Company is working to grow its ophthalmic business through further developing and diversifying its product offering via internal development programs, strategic partnerships, and the acquisition of technology to best take advantage of its distribution capabilities. 

Formed in 1987, Escalon Medical is based in Wayne, Pennsylvania. The Company has research and development (R&D), manufacturing, and distribution operations in New Hyde Park, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts. In 2000, Escalon Medical acquired Sonomed, Inc. Since 2000, through acquisition, product divestitures, partnerships, and product development, the Company has grown and expanded its product offerings. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.

All of the Company’s ophthalmic products are branded as Sonomed Escalon. Furthermore, Sonomed Escalon maintains certification for compliance with ISO1385 Quality Management Systems for Medical Devices. Escalon Medical markets its products through independent sales representatives, primarily to teaching institutions, hospitals, and eye surgery centers.

The Sonomed Escalon group is a leader in ophthalmic diagnostics imaging. Sonomed Escalon provides ultrasound, digital photography, and image management systems. These products have previously been marketed under the Sonomed, Escalon Digital Solutions, and Escalon/Trek Medical brands.

Sonomed Escalon Rx products include mydriatics/cyclopegics; diagnostic supplies; anesthetics/combo products; antibiotics, steroid combination; injectable dyes, surgical products, and office products. Its surgical solutions include vitreoretinal gases and devices. Its diagnostic solutions include AXIS image management; ophthalmic ultrasound; mobile vison analysis; adaptive refractor; perimetry; digital imaging, and tonometry.

Escalon Medical’s products include an array of ophthalmic ultrasound, digital imaging and photography, and image management systems. The Company’s products also include surgical products, including intraocular gases, fiber optic light guides and sources, and other surgical vitreoretinal instruments.

Sonomed Escalon offers its Vu Pad in regards to Ophthalmic Ultrasound. This is a new class of ophthalmic ultrasound versatility. It is configurable with B-scan, A-scan, UBM or any combination.

Escalon Medical Corp. (ESMC), closed Monday's trading session at $0.1399, up 16.58%, on 11,850 volume with 6 trades. The average volume for the last 60 days is 10,260 and the stock's 52-week low/high is $0.07/$0.73.

Her Imports (HHER)

OTC Markets, MarketWatch, and Marketwired reported on Her Imports (HHER), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Established in 2011, Her Imports is a foremost retailer of human hair extensions and related beauty products. The OTCQB-listed Company sells human hair extensions and related hair-care and beauty products at retail locations across the United States and on its Website. The company previously went by the name EZJR, Inc. It changed its corporate name to Her Imports in January of this year. Her Imports is headquartered in Las Vegas, Nevada.

As of March 31, 2017, Her Imports had 35 retail locations. The Company sells human hair products, including clip-ins and wigs under the Her Imports brand; haircare products, including different shampoos and conditioners, and adhesives under the OSIworks brand. It also sells beauty products and related accessories consisting of silk bonnets, and also styling tools under the Her Imports brand and makeup products under the Skin & Yang brand. 

Recently, Her Imports announced the appointment of four new independent Directors, effective immediately: Aric Perminter; Alex Wong; Dr. Karen MacDonald; and Dr. Faisal Razzaqi. Mr. Barry Hall, Chief Executive Officer and Chief Financial Officer of the Company, remains as Chairman of the Board. Mr. Hall is the only non-independent Board member.

Her Imports also recently reported its financial results for Q2 and first six months ended June 30, 2017. The Company produced record revenue of $4.6 million and $9.0 million during each period respectively.

Revenue totaled $4.6 million for Q2 2017, versus $3.4 million. This represents an increase of 35 percent from Q2 2016. The year-over-year increase of 14.7 percent in consultation studio revenue was chiefly because of the new consultation studios opened in Q4 2016 and Q1 2017. Moreover, online sales grew by 99.5 percent year-over-year.

The Company had Income from Operations of $40,444 for the three months ended June 30, 2017. This is in comparison to a Loss from Operations of $295,280 for the three months ended June 30, 2016.

Last week, Her Imports announced the promotion of Ms. Tippi Shorter as President of Her Imports. Ms. Shorter joined Her Imports earlier in 2017 as Vice President of Product Development & Marketing. She has been the go-to hair artist for many of the world's leading celebrities.

Mr. Barry W. Hall, Her Imports' Chief Executive Officer, stated, "Tippi's expertise and experience have significantly contributed our development as a growing company over the past six months. Now we are ready to move to the next stage in providing beauty products to our customers and Tippi will be leading this endeavor." 

Her Imports (HHER), closed Monday's trading session at $1.20, even for the day, on 2 volume with 1 trade. The average volume for the last 60 days is 314 and the stock's 52-week low/high is $0.21/$5.00.

The American Energy Group, Ltd. (AEGG)

InvestorsHub and MarketWatch reported on The American Energy Group, Ltd. (AEGG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The American Energy Group, Ltd. (AEGG) is an energy resource royalty company. It is a non-operating oil and gas organization. AEGG has an 18 percent gross overriding royalty interest on the producing Yasin Block 2468-7 in South-Central Pakistan. This consists of 539,172 acres. AEGG is headquartered in Westport, Connecticut. The Company’s shares trade on the OTC Markets Group’s OTCQB.

AEGG exposes investors to the considerable upside of drilling activities in Pakistan. This is without the downside risk of exploration and production costs. The original oil producing well in Pakistan dates back to 1887. However, significant gas reserves were not discovered in the country until 1952. Regarding Pakistan in-country opportunities, experts view Pakistan as a country with realistic potential for the discovery of large oil and gas reserves. 

The Company’s other core assets consist of royalties and convertible carried working interests (WIs) in oil and gas leases. These include a 2.5 percent carried working interest (WI) in Zamzama North Block No. 2667-8 under exploration in South-Central, Sindh Province, Pakistan. Heritage Oil and Gas is the operator; the property comprises 557,951 square acres. 
 
AEGG also has a 2.5 percent carried WI in Sanjawi Block No. 3068-2 under exploration North-Central, Baluchistan Province, Pakistan. Heritage Oil and Gas is the operator; the property is 302,895 square acres. The other joint venture partners are Hycarbex-American Energy, Inc, Sprint Energy, and Trakker Energy. 

Furthermore, in the Zamzama North and Sanjawi Blocks, the Company has the option to convert its 2.5 percent carried WIs at any time, on a well by well basis to a 1.5 percent royalty, free of the costs of exploration and development of the leases. The convertible carried WI is "carried", which means free of exploration and development costs, as to the initial three wells for Zamzama North, and the first two wells for Sanjawi. 

The American Energy Group, Ltd. (AEGG), closed Monday's trading session at $0.05, even for the day. The average volume for the last 60 days is 25,760 and the stock's 52-week low/high is $0.02/$0.13.

Tiger Reef, Inc. (TGRR)

Investors Hub and MarketWatch reported on Tiger Reef, Inc. (TGRR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Established in 2013, Tiger Reef, Inc. is a diversified producer of ultra premium rums under the Tiger Reef® brand. The Company is also a developer of casual dining restaurant properties in the Caribbean under the Mermaid Reef Ocean Grill & Lounge™ brand. The Company previously went by the name Blue Water Bar & Grill, Inc. It changed its name to Tiger Reef, Inc. in October of 2016. 

Tiger Reef is headquartered in Cole Bay, the Netherlands Antilles. The Company is a subsidiary of BWG Investments & Development, Ltd. Tiger Reef lists on the OTCQB.

Tiger Reef has established a new wholly-owned operating subsidiary in St. Maarten, Dutch West Indies under the name Mermaid Reef, B.V.  Mermaid Reef will own and operate the initial Mermaid Reef Ocean Grill & Lounge™ in St. Maarten. 

Establishing this wholly-owned subsidiary was a mandatory legal development required to formalize the restaurant lease that is now in the final stages of negotiations and also to apply for the required governmental operational licenses and permits.

Tiger Reef announced in May 2017 that its wholly-owned subsidiary, Tiger Reef Spirits, Ltd., entered into a Letter of Intent (LOI) with International Spirits & Beverage Group, Inc. (ISBG). ISBG is a Nevada based alcoholic beverage company. It specializes in the development, marketing, and global sales of innovative wine and spirits brands.

ISBG will assist Tiger Reef with obtaining U.S. regulatory approval for the complete line of Tiger Reef® ultra premium rums. ISBG will also become the U.S. importer of record for Tiger Reef’s complete line of rums.

It will also handle all compliance and regulatory matters required for legally bringing the rums into the United States. ISBG will also facilitate and make important introductions on behalf of Tiger Reef for distribution, marketing, warehousing, and retailing its rums within the U.S.

ISBG has entered into an LOI to import the Caribbean based Tiger Reef® brand of ultra premium rums into the U.S. With this LOI, ISBG will assist Tiger Reef with obtaining U.S. regulatory approval, including COLA and TTB certification and bottle/label design approval, for all three of Tiger Reef’s rums.

In late June of this year, Tiger Reef unveiled the floor plan for the Mermaid Reef Ocean Grill & Lounge™ now being developed at Simpson Bay Resort & Marina on the island of St. Maarten, Dutch West Indies. Key elements of the Restaurant floor plan include the restaurant encompassing 2,466 sq. ft. of indoor and outdoor waterfront space. Outdoor seating includes two newly constructed gazebos, one for dining and one for the lounge. There will be inside and outside seating for roughly 80 diners and the outdoor lounge will seat about 25 guests.

Tiger Reef, Inc. (TGRR), closed Monday's trading session at $0.0055, even for the day, on 2,500 volume with 1 trade. The average volume for the last 60 days is 159,391 and the stock's 52-week low/high is $0.005/$0.17.

graphic

The QualityStocks
Company Corner

graphic
graphic

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2)

The QualityStocks Daily Newsletter would like to spotlight 92 Resources Corp. (RGDCF). Today, 92 Resources Corp. closed trading at $0.0914, up 4.34%, on 149,906 volume with 42 trades. The stock’s average daily volume over the past 60 days is 10,900 and its 52-week low/high is $0.0741/$0.1318.

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) is a modern energy solutions company focused on acquiring and advancing strategic and prospective energy-related projects in Canada. Its three principal assets include the Hidden Lake Lithium Property in the Northwest Territories, the Pontax Lithium Property in Quebec, and the Golden Frac Sand Property in British Columbia.

Preliminary mineralogy work on samples taken of the Hidden Lake pegmatites indicate spodumene – the world's richest source of lithium – is of a high quality and near the maximum theoretical limit. Scoping testwork saw an overall lithium extraction of 97 percent from the concentrate produced from these pegmatites, which means standard lithium extraction techniques can be applied, making the extraction of lithium easier and more cost effective.

92 Resources is focused on developing the lithium-rich resources located within its properties through open-pit mining and relatively straight-forward mineral processing procedures. Surface exploration programs that include prospecting, mapping and sampling of known spodumene-bearing pegmatites on the Hidden Lake property suggests the existence of one massive, interconnected body of pegmatite below the surface. Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio.

Recent acquisitions of prospective hard-rock lithium properties in Quebec add to the company's impressive and growing asset portfolio. The properties, known as Corvette, Eastmain and Lac Du Beryl, consist of a combined 115 mineral claims totaling approximately 14,710 acres with confirmed pegmatite outcrops visible at each location. Some sampling has been completed at the Corvette property and shows spodumene crystals present, making this location a high priority for follow up work. Analytical results are pending on samples taken from known pegmatite outcrops visible at each property.

Lithium is a strategic, green metal used in batteries, electronics, electric vehicles, ceramics, alloys, lubricants and pharmaceuticals. The world market for electric vehicles, with China as its biggest customer, is exponentially growing as the demand for clean, renewable energy sources increases. A recent report by Grand View Research, Inc. places the lithium-ion battery market worldwide at $93 billion by 2025, with a compound annual growth rate of 17%.

92 Resources is led by an experienced management team and advisors with decades of expertise in market strategies, corporate development, mineral exploration and energy development. With an excellent team of professionals and promising mining projects, the company is well positioned to capitalize on the ever-rising demand for lithium. Disclaimer

92 Resources Corp. Blog

92 Resources Corp. News:

92 Resources Corp. Acquires Three New Properties in Quebec

92 Resources Corp. Achieves 97% Li Extraction from Concentrate Produced from the Pegmatites at Hidden Lake

92 Resources Corp. Finalizes Its Exploration Plans for the 2017 Summer/Fall Field Program at Its Hidden Lake Lithium Project

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.399, up 14.00%, on 1,879,313 volume with 570 trades. The stock’s average daily volume over the past 60 days is 353,769, and its 52-week low/high is $0.073/$0.72.

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, announced today an update to its investors and stakeholders on the significant advancements in its proprietary technology for the microbial biosynthesis of cannabinoids.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Continues to Make Significant Strides on Biosynthesis Program Development

InMed Pharmaceuticals Added to CSE25 Index

InMed Pharma: A Leader in Cannabinoid Biosynthesis -- CFN Media

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.1129, up 12.90%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 12,973 and its 52-week low/high is $0.019/$0.20.

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

NetworkNewsBreaks – Alternative Fuel Innovations Propel Greenkraft, Inc. (GKIT) to Success

Greenkraft, Inc. (OTCQB: GKIT) Now Offering an Allison Transmission for Their Alternative Fuel Trucks

Greenkraft, Inc. Publishes 500% Revenue Increase and Continues Positive Momentum by Achieving Near Zero Emissions in Their Trucks

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.0111, up 9.90%, on 14,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 183,526 and its 52-week low/high is $0.002/$0.08.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

NetworkNewsWire Releases Exclusive Audio Interview with AppSwarm, Inc. (SWRM)

AppSwarm, Inc. (SWRM) Engages NetworkNewsWire for Corporate Communications Solutions

AppSwarm Announces Acquisition of Multiplatform Games Developer and Publisher MediaPlay and the Creation of Two Divisions of AppSwarm, Inc.

LottoGopher Holdings Inc. (OTCQB:LTTGF) (CSE:LOTO) (FRA:2LG)

The QualityStocks Daily Newsletter would like to spotlight LottoGopher Holdings Inc. (LTTGF). Today, LottoGopher Holdings Inc. closed trading at $0.1911, up 1.70%, on 410,866 volume with 163 trades. The stock’s average daily volume over the past 60 days is 60,203 and its 52-week low/high is $0.15/$0.50.

LottoGopher Holdings Inc. (LTTGF) is a new lottery messenger service that provides its subscribers with the security of ordering and managing the legal purchase of state lottery tickets online using debit and credit cards. LottoGopher makes it simple for users to keep track of tickets and winnings. Members have exclusive access to strategies, alerts, lottery news and can play alone with a single ticket or join online public or private groups to pool winnings.

LottoGopher is transforming the lottery buying experience, which has historically meant taking the time and spending the gas money to drive to a retail location, then stand in line to buy via cash only and redeem tickets. LottoGopher's uniquely online messenger service streamlines the experience of taking a shot at the lottery and makes it much more convenient and access to electronic payment, otherwise not permitted in CA. While only California residents at this time can play Mega Millions, SuperLotto Plus and Powerball through LottoGopher.com, expansion plans are in the works to allow internet-savvy residents in 22 other states with legal lotteries to have the same advantages of purchasing tickets online.

LottoGopher also enjoys a strategic business relationship with Lottoland, ranked in the Financial Times' FT1000 Report as one of Britain's Top 30 fastest growing companies and as the second ranked gaming company in Europe. Since launching in 2013, Lottoland has rapidly become a world leader in the online lottery sector with nearly $357 million (U.S. dollars) in annual sales.

LottoGopher's currently integrated support systems include a mobile friendly platform; automated email follow-up system to capture, score and remarket to email address leads; social media listening and outreach; utilization of Google Analytics tools; one-time promotional offers across multiple platforms; main and backup credit card processing accounts; and focus on customer service.

Customers of LottoGopher pay a subscription fee to use the service, much like Netflix, Amazon Prime or Dollar Shave Club. After selecting their subscription plan, users pay the same price per ticket as if purchasing from a retail, brick-and-mortar location. LottoGopher's team then secures the selected tickets from a lottery retailer partner. User account balances are updated after a drawing, which makes it impossible for a member to "lose" a winning ticket.

The company's target market includes the 80 million U.S. consumers already buying lottery tickets who typically purchase products online. Offering a far more convenient way to play the lottery via an intuitive platform, LottoGopher is well positioned to disrupt this multi-billion dollar industry. Disclaimer

LottoGopher Holdings Inc. Blog

LottoGopher Holdings Inc. News:

NetworkNewsWire Releases Exclusive Audio Interview with LottoGopher Holdings Inc.

NetworkNewsWire Announces Publication on Successful Subscription Businesses

LottoGopher Holdings Inc. Announces William Shatner as the Company Spokesperson

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Penny Stock Titans
(ERMG) +433.33%

2.

PennyStockScholar
(DDXSQ) +122.22%

3.

Penny Pick Finders
(ITUS) +69.60%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251